Industry
Biotechnology
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Loading...
Open
5.25
Mkt cap
691M
Volume
595K
High
5.50
P/E Ratio
-4.06
52-wk high
7.91
Low
5.23
Div yield
N/A
52-wk low
3.80
Portfolio Pulse from Benzinga Newsdesk
May 21, 2024 | 3:38 pm
Portfolio Pulse from Benzinga Newsdesk
May 21, 2024 | 11:06 am
Portfolio Pulse from Benzinga Newsdesk
May 21, 2024 | 11:03 am
Portfolio Pulse from Avi Kapoor
April 29, 2024 | 2:47 pm
Portfolio Pulse from Benzinga Newsdesk
April 22, 2024 | 5:20 pm
Portfolio Pulse from Benzinga Newsdesk
March 21, 2024 | 1:25 pm
Portfolio Pulse from Benzinga Insights
March 21, 2024 | 1:05 pm
Portfolio Pulse from Benzinga Newsdesk
March 21, 2024 | 11:31 am
Portfolio Pulse from Benzinga Newsdesk
March 21, 2024 | 11:30 am
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.